{"version":"1.0","type":"link","title":"Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.","author_name":"Mildanoglu MM 외","author_url":"https://prs-insight.online/author/Mildanoglu%20MM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95443","thumbnail_width":1200,"thumbnail_height":630}